Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Primerica
PRI
$10B
| $7.98M | 0.01% |
+90,200
| New | +$10.3M |
|
|
PRNB
1302
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $7.96M | 0.01% |
134,100
+53,700
| +67% | +$3.13M |
|
1303
Embotelladora Andina Series B
AKO.B
$4.93B
| $7.95M | 0.01% |
644,810
-8,804
| -1% | -$131K |
|
|
BRT
1304
BRT Apartments
BRT
$267M
| $7.93M | 0.01% |
773,223
+74,436
| +11% | +$1.15M |
|
1305
Old Second Bancorp
OSBC
$1.32B
| $7.92M | 0.01% |
1,146,225
-69,104
| -6% | -$760K |
|
1306
CEVA Inc
CEVA
$954M
| $7.88M | 0.01% |
316,200
-26,200
| -8% | -$727K |
|
1307
Royal Bank of Canada
RY
$294B
| $7.87M | 0.01% |
127,787
-828,507
| -87% | -$61.5M |
|
|
ZNH
1308
DELISTED
China Southern Airlines Company Limited
ZNH
| $7.82M | 0.01% |
360,000
-38,083
| -10% | -$1.07M |
|
|
CUK
1309
DELISTED
Carnival PLC
CUK
| $7.81M | 0.01% |
655,027
+119,227
| +22% | +$3.99M |
|
1310
Columbia Sportswear
COLM
$2.93B
| $7.81M | 0.01% |
+111,902
| New | +$9.5M |
|
|
ANH
1311
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $7.8M | 0.01% |
6,904,890
+186,400
| +3% | +$567K |
|
1312
Sarepta Therapeutics
SRPT
$1.68B
| $7.79M | 0.01% |
+79,678
| New | +$9.11M |
|
1313
Arthur J. Gallagher & Co
AJG
$64.3B
| $7.78M | 0.01% |
95,400
+7,600
| +9% | +$728K |
|
1314
Tilly's
TLYS
$127M
| $7.78M | 0.01% |
1,882,532
-56,189
| -3% | -$413K |
|
1315
Tenet Healthcare
THC
$21.1B
| $7.77M | 0.01% |
539,475
+511,200
| +1,808% | +$14.7M |
|
|
VLRS
1316
Controladora Vuela Compania de Aviacion
VLRS
$962M
| $7.76M | 0.01% |
2,262,500
+26,752
| +1% | +$260K |
|
|
LN
1317
DELISTED
LINE Corporation
LN
| $7.72M | 0.01% |
160,478
+2,018
| +1% | +$98K |
|
1318
Tejon Ranch
TRC
$444M
| $7.71M | 0.01% |
547,999
-48,001
| -8% | -$737K |
|
1319
Liberty Media Series C
FWONK
$24.1B
| $7.7M | 0.01% |
292,590
-109,416
| -27% | -$4.2M |
|
1320
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
| $7.7M | 0.01% |
254,600
-177,662
| -41% | -$5.43M |
|
1321
Teck Resources
TECK
$32.4B
| $7.68M | 0.01% |
1,014,896
-1,652,541
| -62% | -$19.8M |
|
|
HR
1322
DELISTED
Healthcare Realty Trust Incorporated
HR
| $7.67M | 0.01% |
+274,600
| New | +$9.32M |
|
1323
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $7.67M | 0.01% |
123,000
-82,800
| -40% | -$5.08M |
|
1324
Mesa Laboratories
MLAB
$574M
| $7.66M | 0.01% |
33,900
-32,000
| -49% | -$7.89M |
|
1325
Universal Electronics
UEIC
$60.1M
| $7.66M | 0.01% |
199,700
+44,577
| +29% | +$2.02M |
|
Similar funds
Renaissance Technologies's Q1 2020 Portfolio in Review
As of Q1 2020, Renaissance Technologies held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Renaissance Technologies's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Renaissance Technologies added most to Baidu in Q1 2020, an estimated $462M increase.
- Renaissance Technologies's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Renaissance Technologies fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Renaissance Technologies's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Renaissance Technologies opened 573 new positions and closed 645 in Q1 2020.
- Renaissance Technologies's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.